midazolam 1 mg/ml solution for injection/infusion
as kalceks - midazolam - solution for injection/infusion - 1 milligram(s)/millilitre - midazolam
itraconazole 10mg/ml oral solution
athlone pharmaceuticals limited - itraconazole - oral solution - triazole derivatives; itraconazole
calquence tablet
astrazeneca canada inc - acalabrutinib (acalabrutinib maleate) - tablet - 100mg - acalabrutinib (acalabrutinib maleate) 100mg
calquence capsule
astrazeneca canada inc - acalabrutinib - capsule - 100mg - acalabrutinib 100mg - antineoplastic agents
venclyxto
abbvie ltd - venetoclax - leukemia, lymphocytic, chronic, b-cell - antineoplastic agents - venclyxto monotherapy is indicated for the treatment of chronic lymphocytic leukaemia (cll) in the presence of 17p deletion or tp53 mutation in adult patients who are unsuitable for or have failed a b cell receptor pathway inhibitor.
dormicum injection 5 mg5 ml
dksh singapore pte. ltd. - midazolam - injection - 5 mg/5 ml - midazolam 1 mg/ml
dormicum injection 15 mg3 ml
dksh singapore pte. ltd. - midazolam - injection - 15 mg/3 ml - midazolam 5 mg/ml
sporanox capsule
janssen inc - itraconazole - capsule - 100mg - itraconazole 100mg - azoles
sporanox solution
janssen inc - itraconazole - solution - 10mg - itraconazole 10mg - azoles
jamp itraconazole oral solution
jamp pharma corporation - itraconazole - solution - 10mg - itraconazole 10mg - azoles